Redox-sensitive signaling factors and antioxidants

Farmacia

Volumn 57, Issue 4, 2009, Pages 399-411

  Mohora, Maria ^a   Greabu, Maria ^a   Totan, Alexandra ^a   Mitrea, Niculina ^a   Battino, Maurizio ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antioxidants; Gene expression; Glutathione; Oxidative stress; Thioredoxin; Transcription factors

Indexed keywords

ANTIOXIDANT; CATALASE; ERIOCALYXIN B; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUTATHIONE PEROXIDASE; HELIX LOOP HELIX PROTEIN; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; LEUCINE ZIPPER PROTEIN; METHYLGLYOXAL; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANTIINFLAMMATORY ACTIVITY; CELL FUNCTION; DEFENSE MECHANISM; DNA REPAIR; DRUG TARGETING; EUKARYOTE; GENE EXPRESSION; HOMEOSTASIS; ISODON ERIOCALYX; MEDICINAL PLANT; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 69249212488     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., Huang P., Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10, 1343-1374.
2. Muller F.L., Lustgarten M.S., Jang Y., Richardson A., Van Remmen H., Trends in oxidative aging theories. Free Radic. Biol. Med. 2007, 43, 477-503.
3. Cadenas E., Mitochondrial free radical production and cell signaling. Mol Asp Med. 2004, 25, 17-26.
4. Nathan C., Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6, 3051-3064.
5. Halliwell B., Gutteridge J.M.C., Free radicals in biology and medicine, Oxford University Press, 2007.
6. Mendez J.I., Nicholson W.J., Taylorw.R., SOD Isoforms and Signaling in Blood Vessels: Evidence for the Importance of ROS Compartmentalization. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 887-888.
7. Kisucka J., Chauhan A.K., Patten I.S., Yesilaltay A., Neumann C., Van Etten R.A., Krieger M., Wagner D.D., Peroxiredoxin1 Prevents Excessive Endothelial Activation and Early Atherosclerosis. Circulation Research. 2008, 103, 598.
8. Dröge W., Free radicals in the physiological control of cell function, Physiol Rev. 2002, 82, 47-95
9. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., Channon K.M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002, 105, 1656-1662.
10. Turko I.V., Marcondes S., Murad F., Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA - transferase. Am. J. Physiol. Heart Circ. Physiol, 2001, 281, 2289-2294.
11. Nakamura H., Nakamura K., Yodoi J., Redox regulation of cellular activation. Annu. Rev. Immunol. 1997, 15, 351-369.
12. Masella R., Benedetto R.D., Vari R., Filesi C., Giovannini C., Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione related enzymes. J. Nutr. Biochem. 2005, 16, 577-586.
13. Bindoli A, Fukuto JM, Forman HJ, Thiol Chemistry in Peroxidase Catalysis and Redox Signaling, Antioxidants & Redox Signaling. 10, 1549-1564, 2008.
14. Valko M., Leibfritz D., Moncola J., Mark T.D., Cronin M.T.D., Mazura M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease, Int.J. Biochem. & Cell Biology, 2007, 39, 44-84.
15. Gius D., Spitz D.R., Redox Signaling in Cancer Biology. Antioxidants & Redox Signaling. 2006, 8, 1249-1252.
16. Sun Y., Oberley L.W., Redox regulation of transcriptional activators. Free Radic. Biol. Med. 1996, 21, 335-348.
17. Morel Y., Barouki R., Influence du stress oxydant sur la regulation des genes, Science, 1998, 14, 713-721
18. Chen L.F., Greene W.C., Shaping the nuclear action of NF-kappaB. Nat.Rev.Mol.Cell Biol. 5, 392-40, 2004.
19. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y., NF-kB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004, 431, 461-466.
20. Siebenlist U., Franzoso G., Brown K., Structure, regulation, and function of NF-kappa B, Annu.Rev.Cell Biol. 1994, 10, 405-455.
21. Hayden M.S., Ghosh S., Shared principles in NF- kappa B signaling. Cell. 2008, 132, 344-362.
22. Kabe Y., Ando K., Hirao S., Yoshida M., and Handa H., Redox regulation of NFkappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid.Redox Signal. 2005, 7, 395-403.
23. Perkins N.D., Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat.Rev.Mol. Cell Biol. 2007, 8, 49-62.
24. Gallagher D., Gutierrez H., Gavalda N., O'Keeffe G., Hay R., and Davies A.M., Nuclear factor-kappaB activation via tyrosine phosphorylation of inhibitor kappaB-alpha is crucial for ciliary neurotrophic factor-promoted neurite growth from developing neurons, J.Neurosci. 2007, 27, 9664-9669.
25. Gloire G., Legrand-Poels S., Piette J., NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006, 72, 1493-1505.
26. Toledano M.B., Leonard W.J., Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc.Natl.Acad. Sci. U S A. 1991, 88, 4328-4332.
27. Nishi T., Shimizu N., Hiramoto M., Sato I., Yamaguchi Y., Hasegawa M., Aizawa S., Tanaka H., Kataoka K., Watanabe H., and Handa H., Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J.Biol.Chem. 2002, 277, 44548-44556.
28. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., and Yodoi J., Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J.Biol.Chem. 1999, 274, 27891-27897.
29. Gianluca T.G., Quadrifoglio F., Tiribelli C., Kelley M.R., The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme, Antioxidants & Redox Signaling, 2009, 11, 601-620, 2009
30. Matthews J.R., Botting C.H., Panico M., Morris H.R., and Hay R.T., Inhibition of NFkappaB DNA binding by nitric oxide. Nucleic Acids Res. 1996, 24, 2236-2242.
31. Kelleher Z.T., Matsumoto A., Stamler J.S., and Marshall H.E., NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J.Biol.Chem. 2007, 282: 30667-30672.
32. Collins T., Cybulsky M.I., NF-kB: pivotal mediator or innocent bystander in atherogenesis ? J.Clin.Invest. 2001, 197, 255-264.
33. Leung C.H., Grill S.P., Wing Lam W., Gao W., Sun H.D., Cheng Y.C., Eriocalyxin B Inhibits Nuclear Factor-kB Activation by Interfering with the Binding of Both p65 and p50 to the Response Element in a Noncompetitive Manner. Mol.Pharmacol. 2006, 70, 1946-1955.
34. Raffoul J.J., Banerjee S., Singh-Gupta V., Knoll Z.E., Fite A., Zhang H., Abrams J., Sarkar F.H., and Hillman G.G., Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res. 2007, 67, 2141-2149.
35. Laga M., Cottyn A., Van Herreweghe F., Vanden Berghe W., Haegeman G., Van Oostveldt P., Vandekerckhove J., and Vancompernolle K., Methylglyoxal suppresses TNFalpha- induced NF-kappaB activation by inhibiting NF-kappaB DNA binding, Biochem,Pharmacol. 2007, 74, 579-589.
36. Vousden K.H., Lane D.P., p53 in health and disease. Nat.Rev.Mol.Cell Biol. 2007, 8, 275-283.
37. Petitjean A., Achatz M.I., Borresen-Dale A.L., Hainaut P., Olivier M., TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007, 26, 2157-2165.
38. Riley T., Sontag E., Chen P., Levine A., Transcriptional control of human p53 regulated genes. Nature Reviews Molecular Cell Biology. 2008, 9, 402-412.
39. Yee K.S., Vousden K.H., Complicating the complexity of p53, Carcinogenesis. 2005, 26, 1317-1322.
40. Hussain S.P., Amstad P., He P. et al., p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64, 2350-2356.
41. Budanov A.V., Sablina A.A., Feinstein E., Koonin E.V., Chumakov P.M., Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science. 2004, 304, 596-600.
42. Brooks C.L., Gu W., Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr.Opin.Cell Biol. 2003, 15, 164-171.
43. Kruse J.P., Gu W., MSL2 promotes Mdm2-independent cytoplasmic localization of p53, J.Biol.Chem. 2009, 284, 3250-3263.
44. Buzek J., Latonen L., Kurki S., Peltonen K., Laiho M., Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. Nucleic Acids Res. 2002, 30, 2340-2348.
45. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., and Mann K., Role of cysteine residues in regulation of p53 function. Mol.Cell Biol. 1995, 15, 3892-3903.
46. 2+ on DNA Recognition and Stability of the p53 DNA-Binding Domain. Biochemistry. 2006, 45, 7483-7492.
47. Cho Y., Gorina S., Jeffrey P.D., Pavletich N.P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994, 265, 346-354.
48. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., Aaronson S.A., Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol.Cell Biol. 2003, 23, 8576-8585.
49. Cano C.E., Gommeaux J., Pietri S., Culcasi M., Garcia S., Seux M., Barelier S., Vasseur S., Spoto R.P., Pébusque M.J., Dusetti N.J., Iovanna J.L., Carrier A., Tumor Protein 53-Induced Nuclear Protein 1 Is a Major Mediator of p53 Antioxidant Function, Cancer Res. 2009, 69, 219-226.
50. Vlad. Gruia, Andreea Arsene-Nitulescu, Mohora Maria, Niculina Mitrea, Daniela Gradinaru, Begona Y. Manuel, Correlations between some plasmatic redox parameters in diabetic pacients, Farmacia 2008, 56(6), 692-698
51. Ioana Paduraru, Ofelia Paduraru, Luminita Jerca, Sanda Patrascanu, Modifications of oxidative stress parameters in relationship with modifications of lipidic profile in arterial hypertension, Farmacia 2008, 56(3), 261-266
52. Angela Antonescu, Mariana Mureşan, Otilia Micle, Liana Micle, Luciana Dobjanschi, Laura Vicaş, M. Dorofteiu, Serum oxidative stress parameters and homocysteine levels in patients with renal transplant, Farmacia 2008, 56(3), 352,358